newsfilter
← Latest News
Business Wire·

Cyteir Therapeutics Announces Prioritization of CYT-0851 Development and Extended Cash Runway

- Encouraging early clinical results observed in treating ovarian cancer with CYT-0851 combination therapy - Strategic prioritization of clinical development of CYT-0851 combination therapy for ovarian cancer, together